Skip to main content
Clinical Trials/NCT01389258
NCT01389258CompletedNot Applicable

An Open, Prospective, Multi-center Study to Evaluate OsseoSpeed™ TX Single Implant 3 mm Diameter in the Anterior Maxilla. A 3-years Follow-up Study.

Dentsply Sirona Implants and Consumables3 sites in 1 country45 target enrollmentStarted: June 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
45
Locations
3
Primary Endpoint
Implant Survival

Study Overview

Brief Summary

The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX 3mm diameter implant in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior maxilla up to 3 years after loading. Hypothesis: Early loading of the 3 mm implant is a safe and predictable procedure.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Provision of informed consent
  • Aged 20-75 years at enrollment
  • History of edentulism in the study area of at least two months
  • Neighboring tooth/teeth to the planned crown(s) must have natural root(s)
  • Presence of natural teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned crowns
  • Deemed by the investigator to have a bone height and width suitable for 3.0 mm diameter study implant
  • Deemed by the investigator as likely to present an initially stable implant situation

Exclusion Criteria

  • Unlikely to be able to comply with study procedures, as judged by the investigator
  • Uncontrolled pathologic processes in the oral cavity
  • Known or suspected current malignancy
  • History of radiation therapy in the head and neck region
  • History of chemotherapy within 5 years prior to surgery
  • Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration, as deemed by the investigator
  • Uncontrolled diabetes mellitus
  • Corticosteroids or any other medication that could influence post-operative healing and/or osseointegration
  • Smoking more than 10 cigarettes per day
  • Present alcohol and/or drug abuse
  • Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site)
  • Previous enrollment in the present study
  • Simultaneous participation in another clinical study, or participation in a clinical study during the last weeks prior to enrollment

Arms & Interventions

OsseoSpeed™ TX

Experimental

OsseoSpeed™ TX narrow implants (diameter 3 mm) of lengths 11-15 mm

Intervention: OsseoSpeed™ TX (Device)

Outcomes

Primary Outcomes

Implant Survival

Time Frame: Measured at the 3-year follow-up visit after implant loading.

Implant survival rate evaluated clinically and radiographically.

Secondary Outcomes

  • Condition of the Periimplant Mucosa by Assessment of Probing Pocket Depth (PPD).(Measured at implant loading and at the 3-year follow-up visit after loading.)
  • Condition of the Periimplant Mucosa by Assessment of Bleeding on Probing (BoP).(Measured at implant loading and at the 3-year follow-up visit after loading.)
  • Presence of Plaque(Measured at the 3-year follow-up visit after implant loading.)
  • Implant Stability(Measured at the 3-year follow-up visit after implant loading.)
  • Marginal Bone Level Alteration(Measured at the 3-year follow-up visit after implant loading.)
  • Gingival Zenith Score(Measured at implant loading and at the 3-year follow-up visit after loading.)

Investigators

Sponsor
Dentsply Sirona Implants and Consumables
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials